Trump Criticizes Losers Opposing Iran Deal Amid Republican Concerns Over Geopolitical Stability SpaceX OpenAI and Anthropic May Surpass Berkshire Hathaways Market Value on Debut Polymarket Suggests Centuri Holdings Highlighted as a LowPriced Stock for LongTerm Investors Robotop How Advanced Sewing Machines Could Reshape Global Garment Manufacturing Amgen Releases First Quarter 2026 Earnings Report Key Highlights AI Guardrails Stripped From Meta Google Models Raises Safety Concerns Firefly Neuroscience Inc AIFF Q3 1998 Earnings Steep Earnings Miss as PreRevenue Biotech Faces Cash Burn Headwinds Toro Corp Q4 2025 Earnings Minimal EPS Reported as Stock Declines Shoulder Innovations Inc SI Q1 2026 Earnings NarrowerthanExpected Loss Despite No Reported Revenue CRDO Q1 2026 Earnings EPS Surges Past Estimates Stock Soars Over 12 NMFC Q1 2026 Earnings Narrowly Misses EPS Estimates Amid Stable Operations CMBT Q1 2026 Earnings Strong EPS Beat Fails to Lift Stock Oppenheimer Holdings OPY Holds Steady Near 94 as Trading Volume Signals Caution Ocugen Inc OCGN Holds Steady at 134 Amid Consolidation Key Levels in Focus Talon Capital Corp Warrants TLNCW Hold Steady at 050 as Traders Await Catalyst Real Asset Acquisition Corp Unit RAAQU Drops Over 6 Key Levels to Watch Standard BioTools LAB Nears Support After Slight Decline Amid Cautious Trading Stock Market Futures Edge Higher as US Targets Iran Defense Stocks Like Elbit Systems in Focus MTRN Q1 2026 Earnings EPS Surpasses Estimates Stock Gains 234 Soluna Holdings SLNH Surges Over 21 Key Levels to Watch After the Breakout PRE Q4 2025 Earnings EPS Falls Sharply Short of Expectations Amid Transition MKC Q1 2026 Earnings Strong EPS Beat Amid Market Challenges Cerus Corporation CERS Q1 2026 Earnings Narrower Loss Beats Expectations by Over 75 Design Therapeutics Inc DSGN Q1 2026 Earnings Narrower Loss Surpasses Expectations Amid Quiet Quarter Galectin Therapeutics Q1 2026 Earnings EPS Misses Estimates Stock Rallies on Operational Progress OCUL Q1 2026 Earnings WiderThanExpected Loss as Ocular Therapeutix Advances Pipeline CarMax Q1 2026 Earnings EPS Surges Past Estimates with 468 Surprise